ECDC Warns of Rising Antibiotic Resistance Risk

European health officials report a 72 percent surge in Klebsiella pneumoniae infections as antibiotic reduction targets remain unmet.

The European Centre for Disease Prevention and Control (ECDC) has issued a stark warning regarding the rise of antibiotic resistance across Europe. Data shows a significant surge in dangerous pathogens, with bloodstream infections caused by Klebsiella pneumoniae increasing by 72 percent. Additionally, infections involving resistant E. coli bacteria are on the rise, posing a severe threat to public health as these pathogens can lead to life-threatening sepsis when they enter the bloodstream.

Progress in consumption vs. rising threats

While the biological threat intensifies, European efforts to curb antibiotic use have shown modest results. In 2025, antibiotic consumption dropped by five percent compared to 2019 levels. However, this progress remains far behind the international target of a 20 percent reduction by 2030. ECDC Director Pamela Rendi-Wagner and other health officials continue to emphasize that antibiotics are ineffective against viral diseases, yet their misuse remains a primary driver of resistance.

Global risks and technological solutions

The scale of the crisis has drawn concern from the World Health Organization (WHO), which warned that increasing resistance could lead to millions of deaths globally. Despite these grim projections, new medical tools are offering a faster response to the crisis. Advanced technologies that analyze the genetic material of bacteria now allow healthcare providers to detect resistant pathogens earlier than previously possible, potentially improving treatment outcomes before infections become untreatable.